Healthcare Value Capital, LLC

CIK

1458461

Location

Woodcliff Lake, NJ

Portfolio Value

Micro $44,233,736

Diversification

Diversified

Filing Date

Global Rank

#5,872 / 6,035 ▲ 25 · as of Sep 2021

Top Industry

Drug Manufacturers - General 64.7%

Period ended 5 years ago

Filed Nov 15, 2021 · 4y

7 quarters · since Mar 2020

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Unknown

Portfolio style

Measured from the filed 13F common-share book for Sep 30, 2021, never from the firm's own description.

Style

Concentrated

The top 10 positions are 90.1% of the book (60%+)

Turnover

Medium turnover

67.8% over the last four quarters (30% to under 100%)

Horizon

Horizon unknown

The value-weighted holding period is at least 4.9 quarters, but 46.3% of the book was already held when coverage starts

Closest benchmark: the S&P 500 as of 2021-09-30, active share 98.1%; sector active share 66.5% against the combined 13F book's sector weights.

Over time 7 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

20 tracked positions · as of Sep 30, 2021 · Δ vs Jun 30, 2021

Top Position

13.9%

+2.4 pts

Top 5

53.9%

+9.1 pts

Top 10

83.0%

+7.4 pts

HHI

819

Diversified+134

Portfolio Trend

7 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2021

Sector	% Portfolio	Value	Positions
Healthcare	69.0%	$30,540,736	10
Unclassified	29.1%	$12,863,000	9
Consumer Defensive	1.9%	$830,000	1

Last Quarter's Activity

Export CSV

Sep 30, 2021 vs Jun 30, 2021

Added To

Positions the filer increased

2 positions

Ticker	Δ Shares	Shares	Value
—	+500,000	2,000,000	$2,060,000
—	+25,000	100,000	$392,000
No positions match the current search.

Trimmed

Positions the filer reduced

4 positions

Ticker	Company	Δ Shares	Shares	Value
VYNE	Yarrow Bioscience, Inc.	−50,000	400,000	$556,000
ALKS	Alkermes plc.	−50,000	100,000	$3,084,000
PFE	Pfizer Inc	−25,000	75,000	$3,225,750
GILD	Gilead Sciences, Inc.	−15,000	60,000	$4,191,000
No positions match the current search.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
VRTX	Vertex Pharmaceuticals Inc	5,000	$906,950
No positions match the current search.

Sold Out

Positions the filer fully exited

2 positions

Ticker	Company	Shares	Value
COLL	Collegium Pharmaceutical, Inc	100,000	$2,364,000
MDXG	Mimedx Group, Inc.	125,000	$1,563,750
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

20 tracked positions · $44,233,736 total · filing declares 25 positions · $50,652,000 · as of Sep 30, 2021

All sectors Consumer Defensive Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
ALKS	Alkermes plc. PUT + SHARES Healthcare	Added	200,000	+50,000	$6,168,000	+67.7%	3	$21.06	13.94%
PFE	Pfizer Inc PUT + SHARES Healthcare	Added	125,000	+25,000	$5,376,250	+37.3%	3	$35.51	12.15%
GILD	Gilead Sciences, Inc. Healthcare	Reduced	60,000	-15,000	$4,191,000	−18.8%	7+	before history	9.47%
GSK	GSK plc Healthcare	Held	100,000	0	$3,747,636	−4.0%	7+	before history	8.47%
MRK	Merck & Co., Inc. Healthcare	Held	40,000	0	$3,004,400	−3.4%	3	unpriced	6.79%
BMY	Bristol Myers Squibb Co Healthcare	Held	50,000	0	$2,958,500	−11.4%	3	$63.71	6.69%
SPXU	ProShares UltraPro Short S&P500 CALL	Added	150,000	+100,000	$2,631,000	+189.0%	—	—	5.95%
IRWD	Ironwood Pharmaceuticals Inc Healthcare	Reduced	200,000	-50,000	$2,612,000	−18.8%	3	$10.56	5.90%
		Held	500,000	0	$2,230,000	−23.1%	7+	before history	5.04%
		Added	2,000,000	+500,000	$2,060,000	+9.0%	7+	before history	4.66%
		Held	500,000	0	$1,820,000	−16.5%	7+	before history	4.11%
SQQQ	ProShares UltraPro Short QQQ CALL	Added	200,000	+100,000	$1,726,000	+88.8%	—	—	3.90%
UVXY	CALL	NEW	50,000	NEW	$1,228,000	NEW	—	—	2.78%
AMRN	Amarin Corp Plcuk CALL Healthcare	Held	200,000	0	$1,020,000	+16.4%	—	—	2.31%
VRTX	Vertex Pharmaceuticals Inc Healthcare	NEW	5,000	NEW	$906,950	NEW	1	$195.24	2.05%
GNLN	Greenlane Holdings, Inc. Consumer Defensive	Held	350,000	0	$830,000	−47.0%	7+	before history	1.88%
VYNE	Yarrow Bioscience, Inc. Healthcare	Reduced	400,000	-50,000	$556,000	−64.8%	5	unpriced	1.26%
		Held	100,000	0	$491,000	−7.0%	5	unpriced	1.11%
		Added	100,000	+25,000	$392,000	−18.5%	4	unpriced	0.89%
VIXY	CALL	Reduced	12,500	-12,500	$285,000	−52.7%	—	—	0.64%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.